Na+/H+ exchanger regulatory factor 1 (NHERF1) directly regulates osteogenesis

Journal of Biological Chemistry

Volumn 287, Issue 52, 2012, Pages 43312-43321

  Liu, Li ^a   Alonso, Veronica ^a   Guo, Lida ^a   Tourkova, Irina ^a   Henderson, Sarah E ^b   Almarza, Alejandro J ^b   Friedman, Peter A ^a   Blair, Harry C ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE DIFFERENTIATION; BONE DEFECT; BONE FORMATION; BONE MASS; BONE RESORPTION; BONE STRENGTH; DIETARY SUPPLEMENTATION; MATRIX SYNTHESIS; MESENCHYMAL STEM CELL; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; OSTEOGENESIS; PDZ DOMAINS; REGULATORY FACTORS;

CELL CULTURE; ION EXCHANGE; MAMMALS; OSTEOBLASTS; SODIUM;

BONE;

MESSENGER RNA; PARATHYROID HORMONE; PHOSPHATE; REGULATOR PROTEIN; SODIUM PROTON EXCHANGER REGULATORY FACTOR 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE MINERALIZATION; BONE STRENGTH; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; SIGNAL TRANSDUCTION; SODIUM PROTON EXCHANGER REGULATORY FACTOR 1 GENE;

ANIMALS; BONE MATRIX; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHOSPHOPROTEINS; SODIUM-HYDROGEN ANTIPORTER;

MUS;

EID: 84871581529     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.422766     Document Type: Article

References (44)

1. Blair, H. C., Robinson, L. J., Huang, C. L., Sun, L., Friedman, P. A., Schlesinger, P. H., and Zaidi, M. (2011) Calcium and bone disease. Biofactors 37, 159-167
2. Feng, X., and McDonald, J. M. (2011) Disorders of bone remodeling. Annu. Rev. Pathol. 6, 121-145
3. Weinman, E. J., Hall, R. A., Friedman, P. A., Liu-Chen, L. Y., and Shenolikar, S. (2006) The association of NHERF adaptor proteins with G protein-coupled receptors and receptor tyrosine kinases. Annu. Rev. Physiol. 68, 491-505
4. Shenolikar, S., Voltz, J. W., Cunningham, R., and Weinman, E. J. (2004) Regulation of ion transport by the NHERF family of PDZ proteins. Physiology 19, 362-369 (Pubitemid 39636084)
5. + exchanger requires a dissociable phosphoprotein cofactor. J. Clin. Invest. 92, 1781-1786
6. Wang, B., Bisello, A., Yang, Y., Romero, G. G., and Friedman, P. A. (2007) NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling. J. Biol. Chem. 282, 36214-36222
7. Wang, B., Yang, Y., Abou-Samra, A. B., and Friedman, P. A. (2009) NHERF1 regulates parathyroid hormone receptor desensitization. Interference with β-arrestin binding. Mol. Pharmacol. 75, 1189-1197
8. Wheeler, D., Sneddon, W. B., Wang, B., Friedman, P. A., and Romero, G. (2007) NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors. J. Biol. Chem. 282, 25076-25087 (Pubitemid 47347543)
9. Mannstadt, M., Jüppner, H., and Gardella, T. J. (1999) Receptors for PTH and PTHrP. Their biological importance and functional properties. Am. J. Physiol. 277, F665-F675
10. Datta, N. S., and Abou-Samra, A. B. (2009) PTH and PTHrP signaling in osteoblasts. Cell Signal. 21, 1245-1254
11. Shenolikar, S., Voltz, J. W., Minkoff, C. M., Wade, J. B., and Weinman, E. J. (2002) Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc. Natl. Acad. Sci. U.S.A. 99, 11470-11475 (Pubitemid 34920949)
12. Hernando, N., Déliot, N., Gisler, S. M., Lederer, E., Weinman, E. J., Biber, J., and Murer, H. (2002) PDZ-domain interactions and apical expression of type IIa Na/Pi cotransporters. Proc. Natl. Acad. Sci. U.S.A. 99, 11957-11962 (Pubitemid 34994506)
13. + exchange activity in mineralizing osteoblasts. J. Cell. Physiol. 226, 1702-1712
14. Karim, Z., Gérard, B., Bakouh, N., Alili, R., Leroy, C., Beck, L., Silve, C., Planelles, G., Urena-Torres, P., Grandchamp, B., Friedlander, G., and Prié, D. (2008) NHERF1 mutations and responsiveness of renal parathyroid hormone. N. Engl. J. Med. 359, 1128-1135
15. Beck, L., Karaplis, A. C., Amizuka, N., Hewson, A. S., Ozawa, H., and Tenenhouse, H. S. (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. U.S.A. 95, 5372-5377 (Pubitemid 28208605)
16. -/- mice. Bone 29, 467-476
17. Prié, D., Beck, L., Friedlander, G., and Silve, C. (2004) Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization. Curr. Opin. Nephrol. Hypertens. 13, 675-681 (Pubitemid 39506918)
18. Mistry, P. K., Liu, J., Yang, M., Nottoli, T., McGrath, J., Jain, D., Zhang, K., Keutzer, J., Chuang, W. L., Mehal, W. Z., Zhao, H., Lin, A., Mane, S., Liu, X., Peng, Y. Z., Li, J. H., Agrawal, M., Zhu, L. L., Blair, H. C., Robinson, L. J., Iqbal, J., Sun, L., and Zaidi, M. (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc. Natl. Acad. Sci. U.S.A. 107, 19473-19478
19. Manoharan, R., Wang, Y., and Feld, M. S. (1996) Histochemical analysis of biological tissues using Raman spectroscopy. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 52, 215-249
20. Jämsä, T., Jalovaara, P., Peng, Z., Väänänen, H. K., and Tuukkanen, J. (1998) Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23, 155-161 (Pubitemid 28379877)
21. Tropel, P., Noël, D., Platet, N., Legrand, P., Benabid, A. L., and Berger, F. (2004) Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 295, 395-406
22. Bustin, S. A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169-193
23. Wang, B., Means, C. K., Yang, Y., Mamonova, T., Bisello, A., Altschuler, D. L., Scott, J. D., and Friedman, P. A. (2012) Ezrin-anchored PKA coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport. J. Biol. Chem. 287, 24148-24163
24. Roberts, S., Menage, J., and Eisenstein, S. M. (1993) The cartilage end-plate and intervertebral disc in scoliosis. Calcification and other sequelae. J. Orthop. Res. 11, 747-757 (Pubitemid 23320924)
25. Williams, B. O., and Insogna, K. L. (2009) Where Wnts went. The exploding field of Lrp5 and Lrp6 signaling in bone. J. Bone Miner. Res. 24, 171-178
26. Murrills, R. J., Andrews, J. L., Samuel, R. L., Coleburn, V. E., Bhat, B. M., Bhat, R. A., Bex, F. J., and Bodine, P. V. (2009) Parathyroid hormone synergizes with non-cyclic AMP pathways to activate the cyclic AMP response element. J. Cell. Biochem. 106, 887-895
27. +-dependent phosphate transporters in the murine osteoclast. Cellular distribution and protein interactions. Am. J. Physiol. Cell. Physiol. 284, C1633-C1644
28. Brownstein, C. A., Zhang, J., Stillman, A., Ellis, B., Troiano, N., Adams, D. J., Gundberg, C. M., Lifton, R. P., and Carpenter, T. O. (2010) Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse. Endocrinology 151, 492-501
29. Hasegawa, K., Kataoka, K., Inoue, M., Seino, Y., Morishima, T., and Tanaka, H. (2008) Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta. J. Bone Miner. Metab. 26, 394-399 (Pubitemid 351950689)
30. Fratzl-Zelman, N., Roschger, P., Misof, B. M., Nawrot-Wawrzyniak, K., Pötter-Lang, S., Muschitz, C., Resch, H., Klaushofer, K., and Zwettler, E. (2011) Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover. Calcif. Tissue Int. 88, 378-387
31. Saito, M., Fujii, K., and Marumo, K. (2006) Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif. Tissue Int. 79, 160-168 (Pubitemid 44440444)
32. Fratzl-Zelman, N., Valenta, A., Roschger, P., Nader, A., Gelb, B. D., Fratzl, P., and Klaushofer, K. (2004) Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J. Clin. Endocrinol. Metab. 89, 1538-1547 (Pubitemid 38507900)
33. Seeman, E., Delmas, P. D., Hanley, D. A., Sellmeyer, D., Cheung, A. M., Shane, E., Kearns, A., Thomas, T., Boyd, S. K., Boutroy, S., Bogado, C., Majumdar, S., Fan, M., Libanati, C., and Zanchetta, J. (2010) Microarchitectural deterioration of cortical and trabecular bone. Differing effects of denosumab and alendronate. J. Bone Miner. Res. 25, 1886-1894
34. Saeed, H., Abdallah, B. M., Ditzel, N., Catala-Lehnen, P., Qiu, W., Amling, M., and Kassem, M. (2011) Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. J. Bone Miner. Res. 26, 1494-1505
35. Li, B., Shi, M., Li, J., Zhang, H., Chen, B., Chen, L., Gao, W., Giuliani, N., and Zhao, R. C. (2007) Elevated tumor necrosis factor-α suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma. Stem Cells Dev. 16, 921-930
36. Hosogane, N., Huang, Z., Rawlins, B. A., Liu, X., Boachie-Adjei, O., Boskey, A. L., and Zhu, W. (2010) Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int. J. Biochem. Cell Biol. 42, 1132-1141
37. Weinman, E. J., Steplock, D., Donowitz, M., and Shenolikar, S. (2000) NHERF associations with sodium-hydrogen exchanger isoform 3 (NHE3) and ezrin are essential for cAMP-mediated phosphorylation and inhibition of NHE3. Biochemistry 39, 6123-6129 (Pubitemid 30327087)
38. + exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains. J. Biol. Chem. 286, 35020-35029
39. Hartmann, C. (2006) A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 16, 151-158
40. Tobimatsu, T., Kaji, H., Sowa, H., Naito, J., Canaff, L., Hendy, G. N., Sugimoto, T., and Chihara, K. (2006) Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147, 2583-2590
41. Wheeler, D. S., Barrick, S. R., Grubisha, M. J., Brufsky, A. M., Friedman, P. A., and Romero, G. (2011) Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. Oncogene 30, 32-42
42. Romero, G., Sneddon, W. B., Yang, Y., Wheeler, D., Blair, H. C., and Friedman, P. A. (2010) Parathyroid hormone receptor directly interacts with dishevelled to regulate β-catenin signaling and osteoclastogenesis. J. Biol. Chem. 285, 14756-14763
43. Weinstein, R. S., Jilka, R. L., Almeida, M., Roberson, P. K., and Manolagas, S. C. (2010) Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151, 2641-2649
44. Takahashi, Y., Morales, F. C., Kreimann, E. L., Georgescu, M. M. (2006) PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J. 25, 910-920 (Pubitemid 43292451)